Saturday, 20 April 2024
Foamix Pharmaceuticals Ltd.
-
Overlay
-
Indicators
-
Settings
-
Period
Among 3 analysts covering Foamix Pharmaceuticals (NASDAQ:FOMX), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive.
more»
01:56 | 7/3/18
GlobeNewswire
REHOVOT, Israel, and BRIDGEWATER, N.J., March 06, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to ...
more»
01:56 | 1/3/18
GlobeNewswire
REHOVOT, Israel, and BRIDGEWATER, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to ...
more»
01:11 | 28/2/18
Simply Wall St
Foamix Pharmaceuticals Ltd (NASDAQ:FOMX), which has zero-debt on its balance sheet, can maximize capital returns by increasing debt due to its lower cost of capital.
more»
06:15 | 18/2/18
The Ledger Gazette
Foamix Pharmaceuticals logo News stories about Foamix Pharmaceuticals (NASDAQ:FOMX) have been trending somewhat positive this week, according to Accern Sentiment.
more»
01:56 | 14/2/18
GlobeNewswire
REHOVOT, Israel, and BRIDGEWATER, N.J., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical foams to ...
more»
16:22 | 12/2/18
StockNewsTimes
Foamix Pharmaceuticals logo Foamix Pharmaceuticals Ltd (NASDAQ:FOMX) insider Meir Eini sold 5,000 shares of the stock in a transaction dated Monday, January 8th.
more»
03:37 | 12/2/18
The Ledger Gazette
Foamix Pharmaceuticals logo Jennison Associates LLC lowered its stake in shares of Foamix Pharmaceuticals Ltd (NASDAQ:FOMX) by 4.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission.
more»
22:33 | 5/2/18
StockNewsTimes
Foamix Pharmaceuticals logo Foamix Pharmaceuticals Ltd (NASDAQ:FOMX) insider Meir Eini sold 5,000 shares of Foamix Pharmaceuticals stock in a transaction on Tuesday, January 2nd.
more»
Analysts expect Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) to report $-0.46 EPS on February, 20.They anticipate $0.15 EPS change or 48.39 % from last quarter's $-0.31 EPS.
more»